Global Diabetes Management Devices Market Size and Forecast up, 2018

Diabetes Management Devices market status and forecast, categorizes the global Diabetes Management Devices market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, India, Southeast Asia and other regions (Central & South America, and Middle East & Africa).
Diabetes management devices include insulin delivery systems and blood glucose monitoring devices, which are used to treat diabetes effectively and efficiently with fewer side effects. Diabetes (type 1 and type 2) is a chronic disease condition, which occurs due to glucose impairment. The major factors contributing to the disease include obesity, urbanization, sedentary lifestyle, smoking, an elevated level of cholesterols, and hypertension. Vendors in this market are offering high-end insulin delivery systems (less invasive, sleek, pocket-sized, and portable devices) and continuous glucose monitoring systems, which are highly efficient and have user-friendly features.
Diabetes is a chronic disease and is increasing at a rapid pace across the world. It is that state in the body when the pancreas cannot produce sufficient insulin. Increasing blood sugar level can be a threat and can cause severe damage to the body. The study identifies rising global burden of diabetes as one of the primary growth factors for diabetes management devices market. Factors responsible for increase in diabetic population include obesity, smoking, sedentary lifestyle, and growing urbanization. Older people above 65 years are more prone to diabetes. Countries such as China and India have higher diabetic people due to the increase in obesity and urbanization. Owing to the increase in diabetic population across the world, there is increase in adoption of diabetes management devices.
Owing to the presence of several large and small players, the diabetes management devices market is highly competitive. To sustain the competition in the diabetes devices market, the vendors are heavily investing in R&D for designing, developing, and manufacturing innovative products. Currently, the emerging markets across the globe provide huge growth opportunities to the vendors in this marketspace.
The Americas will be the major revenue contributor to the diabetes management devices market throughout the forecast period. Owing to the advancements in technology and the increasing incidence of type 1 and type 2 diabetes, there is an upsurge in the adoption of diabetes management devices in this region.
The global Diabetes Management Devices market is valued at xx million US$ in 2017 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2018-2025.
The major manufacturers covered in this report
    Abbott
    Dexcom
    F. Hoffmann-La Roche
    LifeScan
    Medtronic
    AgaMatrix
    Animas
    ARKRAY
    Ascensia Diabetes Care
    B. Braun Melsungen
    BD
    Beta Bionics
    Bigfoot Biomedical
    BIONIME USA
    CellNovo
    Eli Lilly
    iHealth Labs
    Insulet
    Nemaura Medical
    Nipro
    Nova Biomedical
    Novo Nordisk
    Panasonic Healthcare
    Prodigy Diabetes Care
    Sanofi
    Senseonics
    Tandem Diabetes Care
    Trividia Health
    TypeZero Technologies
    Valeritas
    WellDoc

Comments

Popular posts from this blog

Global Differential Thermal Analyzer Industry Sales & Share by Company, 2019 - 2024

Global Incident Response System Market Key factors of long term success

Aerosol Market Revenue And Industry Forecasts Till, 2021 to 2030: Innovation Market Research